ertapenem has been researched along with Bacteremia in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 21 (46.67) | 24.3611 |
| 2020's | 13 (28.89) | 2.80 |
| Authors | Studies |
|---|---|
| Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P | 1 |
| Goering, RV; Hanson, ND; Kurpiel, PM; Palepou, MF; Wolter, DJ; Woodford, N | 1 |
| Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Anjan, S; Bauerlein, JE; Breda, JR; Cardenas-Alvarez, JL; Ghodsizad, A; Loebe, M; Motoa, G; Munagala, MR; Natori, Y; Phancao, A; Simkins, J; Suarez, J; Thakkar-Rivera, N | 1 |
| Hayney, M; Rose, W; Sakoulas, G; Smelter, D | 1 |
| Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
| O'Neill, TJ; Pisani, B; Wilsey, HA | 1 |
| Jung, EJ; Jung, Y; Kim, JY; Lee, J; Park, JJ; Seo, YB | 1 |
| Alegría, Y; Cruz, R; López, E; Meneses, C | 1 |
| Baek, S; Hwang, JE; Jeong, H; Jo, YH; Kang, JH; Kim, D; Kim, S; Kwon, H; Lee, JH; Park, I; Park, SJ | 1 |
| Bouchard, J; Edwards, L; Hitchins, M; O'Mara, K | 1 |
| Desman, G; Lenskaya, V; Moll, EH; O'Connor, M | 1 |
| Holmes, AH; Nasomsong, W; Panuvatvanich, B; Rawson, TM; Vasikasin, V | 1 |
| Akyol, D; Arda, B; Avşar, CB; Başkol, D; Bozbıyık, O; Bozkurt, D; Çilli, F; Erdem, HA; Kahraman, Ü; Kaya, A; Kenanoglu, B; Korkmaz, P; Memetali, S; Mert, M; Önal, AU; Önal, U; Özgiray, E; Pullukçu, H; Şanlıdağ, G; Şimşir, A; Sipahi, OR; Taşbakan, MI; Ulusoy, S; Yamazhan, T | 1 |
| Geriak, M; Haddad, F; Murray, BE; Nizet, V; Sakoulas, G; Singh, KV; Ulloa, ER | 1 |
| Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H | 1 |
| Frasquet-Artes, J; Garrido-Jareño, M; López-Hontangas, JL; Tasias-Pitarch, M | 1 |
| Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
| Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Avdic, E; Carroll, KC; Cosgrove, SE; Smith, JM; Tamma, PD; Zhang, L | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J | 1 |
| Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL | 1 |
| Chelaghma, W; Kassah-Laouar, A; Loucif, L; Messala, A; Rolain, JM; Saidi, M | 1 |
| Bitterman, R; Geffen, Y; Paul, M; Polak, D | 1 |
| Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
| Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L | 1 |
| Cuadrado Pastor, JM; Jover Díaz, F; Martín González, C; Mayol Belda, MJ | 1 |
| Matull, WR; Morgan, MY; O'Beirne, J; O'Neill, S; Smith, R; Wright, G; Zambreanu, L | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Bencardino, A; Carattoli, A; Falcone, M; García-Fernández, A; Gianfreda, R; Giordano, A; Orsi, GB; Venditti, C; Venditti, M | 1 |
| Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS | 1 |
| Chang, HJ; Chia, JH; Kuo, AJ; Lee, MH; Liu, SW; Wu, TL | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Koh, TH; Krishnan, PU; Lim, TP; Lye, D; Marimuthu, K; Ng, TM; Tan, TY; Teng, C | 1 |
| Goldstein, EJ | 1 |
| Allouch, P; Decousser, JW; Methlouthi, I; Pina, P | 1 |
| Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
| Chan, J; Chen, HH; Lye, DC; Teng, CP | 1 |
| Fung, CP; Huang, SS; Lee, CW; Lee, N; Lee, SC; Shieh, WB; Siu, LK | 1 |
1 review(s) available for ertapenem and Bacteremia
| Article | Year |
|---|---|
First case of renal abscess by Parvimonas micra.
Topics: Abdominal Abscess; Aged; Anti-Bacterial Agents; Bacteremia; Clindamycin; Dental Plaque; Early Diagnosis; Ertapenem; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Opportunistic Infections; Postoperative Complications; Pyelonephritis; Tooth Extraction | 2019 |
44 other study(ies) available for ertapenem and Bacteremia
| Article | Year |
|---|---|
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity | 2007 |
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Genetic Variation; Hydrolysis; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult | 2010 |
Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Heart Transplantation; Heart-Assist Devices; Humans; Methicillin; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin-1 Beta?
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Humans; Interleukin-1beta; Methicillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Ertapenem; Heart-Assist Devices; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ertapenem; Escherichia coli; Humans; Klebsiella pneumoniae; Retrospective Studies | 2022 |
[Enterobacter cancerogenus bacteremia in a patient with pelvic trauma].
Topics: Adult; Bacteremia; Chile; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Humans; Male | 2022 |
Changes in Biomarkers and Hemodynamics According to Antibiotic Susceptibility in a Model of Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Biomarkers; Ertapenem; Escherichia coli; Hemodynamics; Male; Sepsis; Swine; Triggering Receptor Expressed on Myeloid Cells-1 | 2022 |
Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Ertapenem; Humans; Infant, Newborn; Methicillin; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Relapsing
Topics: Adult; Antibiotic Prophylaxis; Bacteremia; Cellulitis; Ertapenem; Helicobacter Infections; Humans; Male; Recurrence; Young Adult | 2022 |
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Ertapenem; Escherichia coli; Humans; Propensity Score; Prospective Studies; Shock, Septic | 2023 |
Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases.
Topics: Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Ertapenem; Humans; Klebsiella pneumoniae; Meropenem; Salvage Therapy | 2023 |
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Methicillin; Rats; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2014 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections | 2016 |
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins | 2016 |
Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.
Topics: Algeria; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Conjugation, Genetic; Disease Outbreaks; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nephritis; Phylogeny; Plasmids | 2016 |
Morphological changes induced by β-lactam antibiotics observed on Gram staining.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ertapenem; Gentian Violet; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Osteomyelitis; Phenazines | 2017 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections | 2008 |
[Multiple inflammatory liver pseudotumors and Enterococcus durans bacteremia].
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biopsy, Needle; Diagnosis, Differential; Enterococcus; Ertapenem; Gram-Positive Bacterial Infections; Granuloma, Plasma Cell; Humans; Liver Abscess; Liver Diseases; Male; Middle Aged | 2009 |
Recurrent bacteremia due to retained embolized glue following variceal obliteration.
Topics: Adult; Bacteremia; beta-Lactams; Embolism; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Ertapenem; Escherichia coli Infections; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Recurrence; Risk Assessment; Severity of Illness Index; Tissue Adhesives; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Ertapenem; Female; Genotype; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Porins; Risk Factors; Treatment Outcome | 2011 |
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins | 2012 |
Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Ertapenem; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Thienamycins; Treatment Outcome | 2013 |
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 2007 |
Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria, Aerobic; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan | 2007 |